key: cord-0972635-2a8v2rxh
authors: Sulis, Giorgia; Basta, Nicole E.; Wolfson, Christina; Kirkland, Susan A.; McMillan, Jacqueline; Griffith, Lauren E.; Raina, Parminder
title: oInfluenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal Study on Aging (CLSA)
date: 2021-12-04
journal: Vaccine
DOI: 10.1016/j.vaccine.2021.11.088
sha: 995f1118db345c2c6bed4890fe15032d32878fbc
doc_id: 972635
cord_uid: 2a8v2rxh

Introd uction Understanding how influenza vaccine uptake changed during the 2020/2021 influenza season compared to previous pre-pandemic seasons is a key priority, as is identifying the relationship between prior influenza vaccination and COVID-19 vaccine willingness. METHODS: We analyzed data from a large, nationally representative cohort of Canadian residents aged 50 and older to assess influenza vaccination status three times between 2014 and 2020. We investigated: 1) changes in self-reported influenza vaccine uptake, 2) predictors of influenza vaccine uptake in 2020/2021, and 3) the association between influenza vaccination history and self-reported COVID-19 vaccine willingness using logistic regression models. RESULTS: Among 23,385 participants analyzed for aims 1-2, influenza vaccination increased over time: 14,114 (60.4%) in 2015-2018, 15,692 (67.1%) in 2019/2020, and 19,186 (82.0%; combining those already vaccinated and those planning to get a vaccine) in 2020/2021. After controlling for socio-demographics, history of influenza vaccination was most strongly associated with influenza vaccination in 2020/2021 (adjusted odds ratio [aOR] 147.9 [95%CI: 120.9-180.9]); this association remained after accounting for multiple health and pandemic-related factors (aOR 140.3 [95%CI: 114.5-171.8]). To a lesser degree, those more concerned about COVID-19 were also more likely to report influenza vaccination in fall 2020, whereas those reporting a very negative impact of the pandemic were less likely to get vaccinated. Among 23,819 participants with information on COVID-19 vaccine willingness during the last quarter of 2020 (aim 3), prior influenza vaccination history was most strongly associated with willingness to get a COVID-19 vaccine (aOR 15.1 [95%CI: 13.5-16.8] for those who had gotten influenza vaccine at all previous timepoints versus never). CONCLUSIONS: Our analysis highlights the importance of previous vaccination in driving vaccination uptake and willingness. Efforts to increase vaccination coverage for influenza and COVID-19 should target individuals who do not routinely engage with immunization services regardless of demographic factors.

Influenza is among the top ten causes of death in Canada, with approximately 12, 200 hospitalizations and 3,500 deaths reported annually [1] . Adults 65 years of age and older are at increased risk of severe disease, hospitalization, and death due to influenza compared to younger individuals [2] . In Canada, an influenza vaccine is strongly recommended for people at risk of influenza-related complications or hospitalization including individuals aged 65 years and older and adults aged 18-64 with chronic medical conditions (CMC), and other selected vulnerable populations [3] . Moreover, the Public Health Agency of Canada (PHAC) established ambitious goals to increase influenza vaccine uptake to 80% among these population groups by 2025 [4] .

According to the Seasonal Influenza Vaccination Coverage Survey, between the seasons 2016-2017 and 2019-2020 the coverage level has remained relatively stable below the target threshold (around 70%) among Canadian adults 65 years or older [5, 6] .

With the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since the early months of 2020, even greater emphasis has been placed on the importance of influenza vaccination [7] , particularly among those at risk of severe influenza outcomes, who are also at increased risk of severe disease, complications, and death due to SARS-CoV-2 infection [8, 9] , both to prevent these outcomes and reduce the burden on the healthcare system. However, the coronavirus disease 2019 (COVID- 19) pandemic has prompted the need to re-examine how individuals perceive their disease risk, how they interact with health services including vaccination, and their attitudes towards the newly developed COVID-19 vaccines. Many questions remain about how the pandemic may impact the uptake of vaccines designed to protect against other infectious diseases.

For these reasons, it is critical to evaluate how influenza vaccine uptake and willingness to get vaccinated changed during the 2020/2021 influenza season in the Northern Hemisphere compared to previous pre-pandemic seasons. In addition, understanding whether an individual's previous history of influenza vaccination over multiple seasons is associated with willingness to receive a COVID-19 vaccine can provide insight into vaccine decision-making and help identify those who are least likely to receive a COVID-19 vaccine.

The Canadian Longitudinal Study on Aging (CLSA) pre-pandemic datasets [10] , together with the 2020 CLSA COVID-19 Questionnaire Study data [11, 12] , provide an opportunity to address these questions and identify those who would most benefit from interventions to increase uptake of influenza vaccine, COVID-19 vaccine, or both in order to inform vaccination efforts during the 2021/2022 influenza season and beyond and optimally prevent the morbidity and mortality caused by these diseases.

Our primary aims were to determine whether and the degree to which influenza vaccine uptake among Canadian adults (overall and across subgroups of interest) changed in 2020 during the COVID-19 pandemic compared to previous years, to examine factors associated with influenza vaccine uptake in the first half of the 2020/2021 influenza season, and to assess whether willingness to receive a COVID-19 vaccine during this same period was associated with prior influenza vaccine uptake based on data collected from the same participants across multiple years.

The CLSA is a large, nationally generalizable cohort of 51,338 Canadian residents aged 45-85 years across 10 provinces at recruitment (between 2011 and 2015). Biological, medical, psychological, social, lifestyle, and economic data are collected from study participants every three years. With 95% retention, 48,893 individuals completed follow-up 1 (2015-2018). To assess the impact of COVID-19 on the physical, mental, social, and economic well-being of older adults, CLSA participants who were still alive and could be contacted (n = 42,511) were invited to participate in the COVID-19 Questionnaire Study starting on April 15, 2020. In total, 28,559 (67.2%) provided informed consent and completed the baseline survey. Multiple weekly, biweekly and monthly surveys took place after the initial contact, and participants who had responded to any previous survey were asked to complete an exit survey at the end of 2020.

Detailed CLSA methods are described elsewhere [10, 13] , and all survey questionnaires are accessible on the CLSA website [14] . Supplementary Figure S1 

We analysed data collected during the core CLSA baseline study visit (carried out between 2011 and 2015), the core CLSA follow-up 1 study (conducted between 2015 and 2018) as well as the baseline (April 15 to May 30, 2020) and exit CLSA COVID-19 questionnaires (September 29 to December 29, 2020) to investigate changes in self-reported influenza vaccine uptake over time and the association with self-reported willingness to get a COVID-19 vaccine at the end of 2020.

For simplicity, from now on we will refer to these three data collection time points as T0, T1, T2 and T3, respectively (Supplementary Figure S2) . To address our first two aims, self-reported influenza vaccine uptake was the   outcome of interest, assessed at three points in time among CLSA participants: at T1 with respect   to the previous 12 months, at T2 with respect to the 2019/2020 season, and at T3 with respect to the 2020/2021 season. Participants could indicate whether they had received influenza vaccine during the relevant period by responding "Yes", "No" or "I don't know/No answer". Since the T3 questionnaire occurred during the influenza season, participants could also indicate that they were planning to receive an influenza vaccine, in addition to indicating whether they already had received one. For the purpose of this analysis, having received an influenza vaccine and planning to receive it in the 2020/2021 season (T3) were combined into a single category. This decision was justified because we found almost no difference in terms of sociodemographic characteristics between individuals who had already been vaccinated and those who reported that they were planning to get a vaccine, the only exception being the distribution of respondents by province of residence. In particular, Quebec residents represented only 4.8% of those already vaccinated and 19.8% of those planning to receive a vaccine, likely reflecting the later start of the vaccination campaign compared to other provinces (Supplementary Table S1 ). The outcome of interest for our third objective was self-reported willingness to receive a COVID-19 vaccine once available (i.e. "willingness"), assessed at T3, i.e. between September and December 2020.

In line with prior analyses that focused solely on factors associated with COVID-19 vaccine willingness [15] , this outcome was categorized as "likely" if participants answered either "very likely" or "somewhat likely", and "unlikely" if they answered "uncertain", "somewhat unlikely", or "very unlikely".

To examine the association between history of influenza vaccination and influenza vaccine uptake at T3, we created a composite variable indicating whether participants reported having received an influenza vaccine at any previous timepoint (never, only at T1, only at T2, at both time points). To evaluate the relationship with participants' willingness to receive a COVID-19 vaccine, prior influenza vaccination history was categorized as "not vaccinated at any timepoint (T1 to T3)", "vaccinated at one timepoint (T1 or T2 or T3), "vaccinated at two of three timepoints", "vaccinated at all timepoints (T1 to T3)", "information not available for one or more timepoints". Sociodemographic variables. Across our analyses, we considered the following sociodemographic variables: 1) sex at birth (male or female), age group (50-54, 55-64, 65-74, 75 and older), race (white or non-white), highest education level (less than secondary school graduation, secondary school graduation, some post-secondary education, post-secondary degree), annual household income (in Canadian dollars; < $20,000, $20,000 to < $50,000, $50,000 to < $100,000, $100,000 to < $150,000, $150,000 or greater), province of residence (10 provinces), and geographic location (urban or rural). Age categories were obtained from the participant's age recorded at T1 or T2 depending on the analysis. Sex, race, and education were obtained from the CLSA baseline study visit (T0); household income data were drawn from the follow-up 1 study visit (T1); province and geographic location were from the COVID-19 baseline survey (T2). These variables were assumed to remain reasonably stable over time among older adults.

COVID-19-related factors. Aside from sociodemographic factors described above, we evaluated the relationship between the outcomes of interest and key factors reflecting the individual's health status throughout 2020 as well as their experience with the pandemic. These included:

self-reported general health status, measured on a scale from 1 (excellent) to 5 (poor); having chronic conditions that are known to increase the risk of severe or fatal COVID-19, i.e. at least one of asthma, chronic obstructive pulmonary disease (COPD), other chronic lung disease, diabetes, hypertension, heart disease, cancer, heart/lung/kidney/liver/pancreas failure; autoimmune disorder, HIV infection; self-reported likelihood of SARS-CoV-2 infection since March 2020, measured on a scale from 1 (very likely) to 5 (very unlikely); having someone close who was ill or died during the COVID-19 pandemic; self-reported concern about COVID-19, measured on a scale from 1 (not at all worried) to 7 (very worried). Finally, we considered selfreported experience of the COVID-19 pandemic impact on participant and household, measured on a scale from 1 (very negative) to 5 (very positive); this variable derived from a question that was intentionally broad in scope, allowing participants to take into account a wide range of experiences related to the pandemic itself and weight the impact of those experiences in the context of their own life. Data about self-reported chronic conditions were collected during the COVID-19 baseline survey (T2), whereas data for all other variables were obtained during the exit survey (T3).

For aims 1 and 2, we restricted our analyses to CLSA participants who had completed the COVID-19 exit survey (n = 24,112) and had available influenza vaccination status for all three timepoints (n = 23,385). For aim 3, we restricted our analyses to CLSA participants who had complete outcome data (COVID-19 vaccine willingness) regardless of missing covariate data (n = 23,819). Influenza vaccine uptake information was missing at one or more time points for 727 (3.0%) individuals and willingness to receive a COVID-19 vaccine was not available for 293 (1.2%) participants; all outcome data were assumed to be missing at random as no associations were identified between missing values and key sociodemographic factors (e.g., age group, sex, race, education, income). Given the small amount of missing data and the assumption of missingness at random, participants with missing outcome data were excluded from the analyses.

Proportions and 95% confidence intervals (CIs) were estimated to describe influenza vaccine uptake at each point in time, both overall and across subgroups of interest based on age group, sex at birth, race, education, household income and area of residence (province and urban/rural location).

We examined the predictors of influenza vaccine uptake in the 2020/2021 season through multivariable logistic regression models. First, we estimated associations between sociodemographic factors (age group, sex at birth, race, education, income, province of residence and geographic location) and the outcome (influenza vaccination in the 2020/21 season, i.e. T3) Given the uncertainty about the actual vaccination status of individuals who had not yet been vaccinated against influenza but were planning to get a vaccine at the time of the survey, we also fitted nested multinomial logistic regression models where the outcome was a three-level variable (unvaccinated and unwilling to get a vaccine [reference group], already vaccinated, and unvaccinated but planning to get a vaccine).

Finally, we examined factors associated with participants' willingness to receive a COVID-19

vaccine. To address this objective, we employed a multivariable logistic regression model Table 1 summarizes the main characteristics of the 23,385 CLSA participants who reported their influenza vaccination status during the three time points considered in this analysis (T1, T2, and T3). Figure 1 provides a graphical representation of how influenza vaccine uptake changed over time from T1 to T2 to T3 and how influenza vaccine uptake relates to willingness to receive a COVID-19 vaccine assessed at T3. (30.3%) had already received influenza vaccination. Since we could not assess whether all those planning to get vaccinated actually received a vaccine, we are unable to judge whether influenza vaccine uptake did increase in the 2020/2021 season compared to the previous years. An increase in uptake would be observed if at least 55% of those planning to get vaccinated eventually followed through. As expected, we found higher proportions of vaccinated persons among older age groups at all timepoints ( Figure 2 ). Influenza vaccination was less frequent at all timepoints among non-white versus white participants, among those living in rural versus urban areas, and among those with lower income (Table 1) . Participants residing in Quebec reported having received the vaccine much less frequently than those from other Canadian provinces, a pattern that remained unchanged over time. We did not observe significant differences in influenza vaccine uptake by sex or across education levels at any time point. Having a history of influenza vaccination was the strongest predictor of influenza vaccine uptake in the 2020/21 season (T3) even after adjusting for all sociodemographic factors (Model 2). Most notably, we estimated a striking aOR of 147.9 (95% CI: 120.9-180.9) for those who reported influenza vaccine uptake both at T1 and T2 compared to those who had not been vaccinated at any timepoint observed.

Based on Model 3, we found that participants who reported that they were more worried about COVID-19 were more likely to undergo influenza vaccination (aOR 4.0 [95% CI: 3.2-5.1] for very worried individuals versus those who were not at all worried). As for the overall impact of the pandemic experienced by the participant and household, those reporting a very negative experience had significantly lower odds of getting vaccinated relative to those who reported that COVID-19 had no effect (aOR 0.6; 95% CI: 0.5-0.8). Having at least one chronic condition among those investigated was associated with slightly higher odds of vaccination (aOR 1.2; 95% CI: 1.1-1.3) compared to having no such conditions. However, self-reported general health status was not associated with influenza vaccination status. Interestingly, believing one was previously infected with SARS-CoV-2 was not associated with influenza vaccine uptake at T3, and similar findings were observed among participants who reported that someone close to them was ill or died during the pandemic. Even after accounting for all of these covariates related to COVID-19 plus demographic factors, history of influenza vaccination was still the most strongly associated with influenza vaccine uptake in the 2020/21 season. Those who reported influenza vaccine uptake both at T1 and T2 had 140.3 times the odds (95% CI: 114.5-171.8) of influenza vaccination in the 2020/21 season (T3) compared to those who had not been vaccinated at any timepoint.

Our sensitivity analysis based on multinomial models (Table S2) further supports our findings about participants who had already received an influenza vaccine at the time of the survey.

Similar associations of a slightly lower magnitude were estimated for those who were unvaccinated at the time of the survey but planning to get vaccinated, suggesting that these individuals were more similar to those already vaccinated in terms of experiences and attitudes towards vaccination compared to unvaccinated participants who did not intend to get a vaccine.

Among 23,819 survey participants who had information on COVID-19 vaccine willingness during the last quarter of 2020, a total of 20,044 (84.2%) responded they were either "somewhat likely" or "very likely" to receive a COVID-19 vaccine once available. The results of our logistic regression model evaluating the association between this outcome and influenza vaccination history and COVID-19-related factors are shown in Figure 4 . After accounting for sociodemographic characteristics and COVID-19-related factors, history of influenza vaccination was the strongest predictor of participants' likelihood to be willing to get vaccinated against COVID-19 (aOR 15.1 [95% CI: 13.5-16.8] for those who received an influenza vaccine at all prior timepoints versus those who had not received it during those timepoints). We also found a stronger association between concern about COVID-19 and participants' willingness to get COVID-19 vaccine as concern increased, ranging from aOR 1.7 (95% CI: 1.5-2.0) for those who gave a score of 2 on a 1 to 7 scale, to aOR 4.4 (95% CI: 3.7-5.3) for very worried individuals (score of 7) relative to those who reported that they were not at all worried. Respondents indicating that the pandemic had a negative overall impact on themselves or their household (versus no effect) were slightly more likely to be willing to get vaccinated (aOR 1.2; 95% CI: 1-1.3 ). Yet, those reporting a very negative impact showed an opposite pattern (aOR 0.8; 95%

CI: 0.6-0.9). Interestingly, having chronic conditions and reporting less than excellent general health status were associated with a lower likelihood of being willing to receive a COVID-19 vaccine even after accounting for the factors described above.

Canada is among countries with the highest vaccination coverage levels among older adults, and previous surveys have shown that the vast majority of older Canadians believe in the importance of vaccines [5] . Yet, over the past few years, influenza vaccine uptake has remained below target uptake levels even among high-risk groups, largely reflecting low perceived susceptibility to influenza [5, [16] [17] [18] . Furthermore, our work indicates that individuals who identified as any racial group other than white, those with lower education, those with lower income, and those residing in Quebec were less likely to receive an influenza vaccine in 2020/2021. These findings are largely consistent with what was observed in previous surveys conducted on the Canadian population [5, 17, 18] .

However, we also found that 83.2% (95% CI: 82.5-83.9) of males and 81.0% (95% CI: 80.3-81.7) of females received or were planning to receive an influenza vaccine in the last quarter of 2020, and no differences in vaccine uptake were detected between sexes after controlling for other sociodemographic factors. This is in contrast with previous reports from the 2013/2014

Canadian Community Health Survey, where -among 33,664 adults aged 65 or older -male participants had significantly higher odds of non-vaccination as compared to females (aOR 1.21;

95% CI: 1.07-1.36) [17] . Similarly, though based on a much smaller sample size (1,950 respondents including 514 aged 65+ from across Canada), the 2015/2016 Influenza Immunization Coverage Survey found lower vaccination rates among males compared to females [18] . Of note, male sex is recognized as a strong risk factor for severe disease and death from COVID-19 [19] . While CLSA participants were not explicitly asked about the reasons for getting or not getting vaccinated against influenza during the 2020/2021 season, the apparently higher vaccine uptake among males observed in our analysis relative to previous studies could possibly reflect an increased perceived risk among this population group due to the pandemic.

Besides looking at the extent and determinants of influenza vaccine uptake, drawing upon our other work on this topic [15] , we also sought to investigate in greater depth the relationship between influenza vaccination history and COVID-19 vaccine willingness during the last quarter of 2020, i.e. before such vaccines became available. Although a strong association between influenza vaccine uptake in the 2020/2021 season and COVID-19 vaccine willingness was documented in another study [15] , in the present study, we found that a history of multiple previous influenza vaccinations is the most important determinant of participants' likelihood of getting vaccinated against COVID-19 even after accounting for many other contributing factors.

In fact, those who reported an influenza vaccination at all previous surveys and had received or planned to receive it also during the 2020/2021 season were 15-fold more likely to get a COVID-19 vaccine versus those who had never been vaccinated for influenza. With respect to other potentially relevant predictors, we found a similar pattern as described for influenza vaccination.

While self-reported concern about COVID-19 may have played a role in favoring vaccine uptake for both influenza and COVID-19, these results suggest that history of influenza vaccination is the strongest predictor of future influenza and COVID-19 vaccination. Thus, interventions that identify those who have not been vaccinated recently and aim to counteract common reasons for vaccine hesitancy and common barriers to vaccination should primarily address underlying determinants of poor vaccine uptake rather than focus on socio-demographic factors or pandemic-specific perceptions.

This study is the first to investigate the predictors of influenza vaccine uptake during the COVID-19 pandemic. Among its major strengths is the use of longitudinal data that were collected at multiple timepoints (before and during the pandemic) from a large and wellestablished national cohort. This allowed us to track changes in vaccine uptake over time and explore associations with a range of factors, including self-reported experiences related to the ongoing pandemic. Another important strength of this study is the joint availability of data about COVID-19 vaccine willingness and influenza vaccination status during the last quarter of 2020.

Since COVID-19 vaccines had not yet been approved for use and made available to the general population at that time, self-reported likelihood of getting vaccinated against COVID-19

presumably reflects individual past experiences with vaccines.

Our study also has some limitations. First, we could have overestimated the level of influenza vaccine uptake during the 2020/2021 season due to the inclusion of individuals who had not yet been vaccinated but were planning to once available, as a proportion of these may have not followed through. As previously mentioned, this choice was motivated by the timing of administration of the COVID-19 exit survey that took place during the first half of the influenza season. At present, no Canadian estimates of influenza vaccine uptake during the 2020/2021 season are available for comparison as we write. Nevertheless, it is worth noting that those planning to receive a vaccine did not significantly differ from those already vaccinated in terms of sociodemographic profile. Second, our surveys did not include specific questions regarding personal reasons for receiving or not receiving an influenza vaccine. While the predictors we evaluated may correlate with an individual's motivation for getting vaccinated or not, our analyses could not directly address attitudes towards vaccination among participants or how these may have changed over time as these data were not collected. Similarly, whether participants had underlying chronic conditions was assessed differently before and during the pandemic, and only the latter was utilized in our analyses. Failure to account for the time-varying nature of this confounder may have led to residual confounding and could explain at least in part why those who were vaccinated more recently were more likely to get vaccinated in the 2020/2021 season compared to those who got vaccinated sometime in the past but not in the previous year. Third, vaccination status was assessed through self-report only, thus potentially overestimating the number of individuals who received a vaccine; however, previous studies have shown that this is generally a valid measure of vaccine exposure [20] , and it is reassuring that our key findings aligned fairly well with past national surveys. Finally, generalizability of our findings to other countries may be limited to those that share similar sociocultural characteristics as well as those that provide accessibility to and affordability of vaccines across population groups. For instance, as influenza vaccine uptake has been shown to increase with education level in this and other studies [5, 17, 18] , it is important to highlight that, in 2019, the proportion of 25-64 year-old Canadians with a tertiary education was 21.4% above the average of the Organization for Economic Cooperation and Development (OECD) member countries [21] . Furthermore, influenza vaccination is publicly funded for priority population groups (e.g. adults aged 65 and older, individuals with chronic conditions) in all Canadian provinces, and most provinces even provide universal vaccination free of charge [22] . This may not be the case in other settings, thus potentially creating additional barriers to vaccine uptake.

With an influenza season coinciding with ongoing efforts to contain COVID-19 and the relaxation of many social distancing, masking, and other public health prevention measures, optimizing vaccination campaigns and reaching those subgroups least likely to be vaccinated remain key priorities. Our study provides insights into the main determinants of influenza vaccine uptake and willingness to get vaccinated during unprecedented times and should be used to inform the improvement of current approaches, tailored to reach hard-to-reach populations who do not routinely access influenza vaccination. The finding that having previously received an influenza vaccine is by far the most important predictor of influenza vaccine uptake as well as of COVID-19 vaccine willingness clearly shows that more efforts must be undertaken to target those who do not routinely engage with immunization services. Therefore, rather than focusing on sociodemographic groups, future efforts aimed to increasing vaccine uptake and actively promote vaccination particularly amongst high-risk individuals should explore avenues to identify and connect with those who do not have a history of accessing immunization services.

To this end, implementing comprehensive immunization registries is an important step to improve surveillance and easily identify those who remain unvaccinated and who may benefit most from outreach. Notes: For the 2020/21 influenza season, participants who had not yet received an influenza vaccine but were planning to get one once available were combined with those who had already been vaccinated. data. Adjusted odds ratios (aORs) and their 95% confidence intervals (CIs) were estimated through logistic regression, (Model 4) controlling for sociodemographic factors (age group, sex at birth, race, education, income, province, and geographic area of residence). All estimates are plotted on the log-odds scale to accommodate extreme values. Table S1 : Sociodemographic characteristics of participants who reported having received an influenza vaccine in the 2020/2021 season, versus those who reported planning to get one once available. Table S2 : Sensitivity analysis for Aim 2. Multinomial logistic regression was used to assess for factors associated with influenza vaccine uptake or willingness to get an influenza vaccine in the 2020/2021 season relative to those who did not get the vaccine and were not planning to. For each outcome level, adjusted odds ratios (aORs) and their 95% confidence intervals (CIs) were estimated using the following models: Model S1 for sociodemographic characteristics; Model S2 for influenza vaccination history, adjusting for all sociodemographics; Model S3, for influenza vaccination history and COVID-19-related factors, controlling for sociodemographics (age, sex at birth, race, education, income, province, and geographic area of residence). 

Flu (influenza): For health professionals

The burden of influenza complications in different high-risk groups: a targeted literature review

Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021

Vaccination Coverage Goals and Vaccine Preventable Disease Reduction Targets by 2025

Public Health Agency of Canada

Seasonal Influenza Vaccination Coverage in Canada

Seasonal Influenza Vaccine Coverage in Canada. Ottawa, Canada: Public Health Agency of Canada

Influenza immunization and COVID-19

Age-specific mortality and immunity patterns of SARS-CoV-2

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, metaanalysis, and public policy implications

Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA)

The Canadian Longitudinal Study on Aging (CLSA)

The Canadian Longitudinal Study on Aging (CLSA)

The Canadian longitudinal study on aging (CLSA)

The Canadian Longitudinal Study on Aging (CLSA)

Factors Associated with Willingness to Receive a COVID-19 Vaccine among Adults Aged 50 years and Older: An Analysis of the Canadian Longitudinal Study on Aging

Trends in influenza vaccine coverage and vaccine hesitancy in

/07 to 2013/14: results from cross-sectional survey data

Determinants of non-vaccination against seasonal influenza

Determinants of non-vaccination against seasonal influenza in Canadian adults: findings from the 2015-2016 Influenza Immunization Coverage Survey

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Validation of self-reported influenza vaccination in the current and prior season. Influenza Other Respir Viruses

Education at a Glance 2020. Organization for Economic Cooperation and Development

Public Funding for Influenza Vaccination by Province/Territory (as of

Post-secondary degree/diploma

T1 = 12 months prior to CLSA Follow-up 1 study visit (data collected between

influenza season, as reported in COVID-19 baseline survey

T3 = During 2020/2021 influenza season, as reported in COVID-19 exit survey

Kirkland reports financial support was provided by Public Health Agency of Canada. Parminder Raina, Christina Wolfson, Susan A. Kirkland reports financial support was provided by Government of Nova Scotia. Parminder Raina, Christina Wolfson, Susan A. Kirkland reports financial support was provided by Canadian Institutes of Health Research. Parminder Raina, Christina Wolfson, Susan A. Kirkland reports financial support was provided by Canada Foundation for Innovation. Parminder Raina, Christina Wolfson, Susan A. Kirkland reports financial support was provided by Provincial Funding from Newfoundland

This research has been conducted using the CLSA Baseline Data Version 3.7 (tracking cohort) and 5.2 (comprehensive cohort), CLSA follow up 1 Data Version 2.2 (tracking cohort) and 3.0 

 Table 1 Influenza vaccine uptake among 23,385 participants at all timepoints, both overall and by sociodemographic characteristics. Total  T1  T2  T3